1 line
3.4 KiB
JSON
1 line
3.4 KiB
JSON
{"Acute myeloid leukaemia": 5.563235931985917, "Alopecia": 2.758326892691253, "Alopecia areata": 5.853647743634364, "Aortitis": 19.790133136971345, "Blood lactate dehydrogenase increased": 2.124833871112354, "Blood magnesium decreased": 4.846376007144799, "Breast cancer metastatic": 10.083868526044066, "Breast cancer recurrent": 30.195068805959075, "Cardiac disorder": 2.871957835538458, "Cardiac dysfunction": 74.86613243387622, "Cardiac failure": 14.30262324488131, "Cardiac failure acute": 7.144756622736439, "Cardiac failure congestive": 2.782753364936093, "Cardiomyopathy": 14.65855317058424, "Cardiotoxicity": 33.84908456206, "Dermatitis acneiform": 4.6161009540491165, "Diarrhoea": 3.973956475916241, "Dilated cardiomyopathy": 8.500444015601486, "Disease progression": 7.698146774538394, "Dry skin": 2.423594277497117, "Ejection fraction abnormal": 12.262746213510905, "Ejection fraction decreased": 86.36710166560017, "Febrile neutropenia": 7.358378751322185, "Granulocyte count decreased": 8.519913535980328, "Granulocytopenia": 4.194343384934607, "HER2 positive breast cancer": 100.46124334043576, "Hair colour changes": 5.160034083773915, "Hair texture abnormal": 9.952475578000737, "Hepatic function abnormal": 2.030584157575595, "Hypersensitivity": 2.044519844185695, "Hypertransaminasaemia": 4.0855247386006255, "Ill-defined disorder": 2.488874156373861, "Infusion related reaction": 13.78088985863785, "Intentional product use issue": 2.451642646884129, "Interstitial lung disease": 6.659204131341141, "Lacrimation increased": 2.6089338111470703, "Left ventricular dysfunction": 15.078983352772816, "Leukopenia": 2.009269440327385, "Lung infiltration": 3.122007351119766, "Lymphoedema": 7.097262975626716, "Lymphoma": 2.0960493033904832, "Madarosis": 20.146285544475266, "Mass": 2.654234136363378, "Metastases to bone": 8.710863335773325, "Metastases to central nervous system": 29.56260290571279, "Metastases to liver": 7.591623934907175, "Metastases to lung": 7.084990561471039, "Metastases to lymph nodes": 7.10243917847237, "Metastasis": 4.809965350308519, "Metastatic neoplasm": 14.712173388250616, "Mitral valve incompetence": 5.941691618514279, "Mucosal inflammation": 8.114971067489925, "Myelosuppression": 18.18597533459476, "Nail disorder": 11.556539537691254, "Neoplasm": 3.380014602364869, "Neuropathy peripheral": 6.444617904675028, "Neutropenia": 3.314032836589881, "Neutrophil count decreased": 8.998534002119026, "No adverse event": 2.3075808163853666, "Oligohydramnios": 7.314465437185395, "Onychoclasis": 9.586571978680464, "Oxygen saturation decreased": 2.0194728600436367, "Palmar-plantar erythrodysaesthesia syndrome": 2.8090431608328625, "Paronychia": 8.513438932237628, "Pericardial effusion": 3.5529399031931543, "Peripheral sensory neuropathy": 3.854672781068957, "Platelet count decreased": 4.771354433435741, "Pleural effusion": 3.845710468354262, "Pneumocystis jirovecii pneumonia": 2.172956973179268, "Pneumonitis": 4.936085658016009, "Polyneuropathy": 3.995612132084032, "Pregnancy": 4.709416242581648, "Pulmonary fibrosis": 2.1951484717100342, "Recurrent cancer": 12.4395004226943, "Red blood cell count decreased": 2.6331414665676496, "Skin fissures": 3.87366899550238, "Stomatitis": 2.890219508815301, "Temperature intolerance": 5.6878798243618585, "Therapy partial responder": 3.295312851944208, "Tumour lysis syndrome": 4.192336474724116, "White blood cell count decreased": 6.7191966983459785} |